CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: New clues to Batten disease

Human Molecular Genetics

Volumn 10, Issue 19, 2001, Pages 2123-2131

  Luiro, Kaisu ^a   Kopra, Outi ^a   Lehtovirta, Maarit ^b   Jalanko, Anu ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLN 3 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL TYPE; CEREBELLUM; CHILDHOOD DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; ENDOSOME; GENE MUTATION; GENETIC CODE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYSOSOME; MOLECULAR BIOLOGY; MOUSE; NERVE CELL; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA CELL; SEMLIKI FOREST ALPHAVIRUS; SYNAPSE; SYNAPSE VESICLE; SYNAPTOSOME; VISUAL IMPAIRMENT; WESTERN BLOTTING;

ALPHAVIRUS; ANIMALIA; SEMLIKI FOREST VIRUS;

EID: 0034772310     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.19.2123     Document Type: Article

References (36)

1. Neuronal ceroid lipofuscinoses in childhood
2. Isolation of a novel gene underlying Batten disease, CLN3
3. Molecular genetics of the neuronal ceroid lipofuscinoses
4. Morphologic diagnosis in neuronal ceroid lipofuscinosis
5. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)
6. Neuronal ceroid-lipofuscinoses in childhood
7. A model for Batten disease protein CLN3: Functional implications from homology and mutations
8. Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p
9. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
10. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro
11. The Batten disease gene product (CLN3p) is a Golgi integral membrane protein
12. Tissue expression and subcellular localization of CLN3, the Batten disease protein
13. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
14. Immunochemical localization of the Batten disease (CLN3) protein in retina
15. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: Implications for infantile neuronal ceroid lipofuscinosis (INCL)
16. Spectrum of mutations in the Batten disease gene, CLN3
17. A v-SNARE participates in synaptic vesicle formation mediated by the AP3 adaptor complex
18. Batten disease: Evaluation of CLN3 mutations on protein localization and function
19. Molecular bases for the recognition of tyrosine-based sorting signals
20. Human palmitoyl protein thioesterase: Evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis
21. Developmental expression of palmitoyl protein thioesterase in normal mice
22. Expression of palmitoyl protein thioesterase in neurons
23. The human CLN2 protein/tripeptidyl-peptidase I is a serine protease T that autoactivates at acidic pH
24. The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum
25. Loss of pigment-laden stellate cells: A severe alteration of the isocortex in juvenile neuronal ceroid-lipofuscinosis
26. Pigmentoarchitectonic pathology of the isocortex in juvenile neuronal ceroid-lipofuscinosis: Axonal enlargements in layer IIIab and cell loss in layer V
27. Morphological alterations in neocortical and cerebellar GABAergic neurons in a canine model of juvenile Batten disease
28. The role of synaptic proteins in Alzheimer's disease
29. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium
30. An antisense transgenic strategy to inhibit the myelin oligodendrocyte glycoprotein synthesis
31. The cytoskeletons of isolated, neuronal growth cones
32. Isolation of synaptosomes, growth cones and their subcellular components
33. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation
34. Proteolytic fragments of Alzheimer's disease-associated presenilin 1 are present in synaptic organelles and growth cone membranes of rat brain
35. Purification of lysosomal membrane proteins from human placenta
36. Cleavage of structural proteins during the assembly of the head of bacteriophage T4